| US 7,601,532 B2 | ||
| Microarray for predicting the prognosis of neuroblastoma and method for predicting the prognosis of neuroblastoma | ||
| Akira Nakagawara, Chiba (Japan); Miki Ohira, Chiba (Japan); Shin Ishii, Ikoma (Japan); Takeshi Goto, Tokyo (Japan); Hiroyuki Kubo, Tokyo (Japan); Takahiro Hirata, Tokyo (Japan); Yasuko Yoshida, Nagoya (Japan); and Saichi Yamada, Ichinomiya (Japan) | ||
| Assigned to Hisamitsu Pharmaceutical Co., Inc., Tosu (Japan); NGK Insulators, Ltd., Nagoya (Japan); and Chiba-Prefecture, Chiba (Japan) | ||
| Filed on Sep. 23, 2004, as Appl. No. 10/947,249. | ||
| Claims priority of provisional application 60/505614, filed on Sep. 25, 2003. | ||
| Prior Publication US 2005/0287541 A1, Dec. 29, 2005 | ||
| Int. Cl. C12M 3/00 (2006.01); C12M 1/34 (2006.01); C07H 21/02 (2006.01); C07H 21/04 (2006.01); C12Q 1/68 (2006.01) | ||
| U.S. Cl. 435—287.2 [536/23.1; 536/24.3; 435/6] | 1 Claim |
| 1. A microarray, comprising:
a first combination of 25 different probes respectively comprising the sequences set forth in SEQ ID NOs: 5, 14, 16, 17, 22,
23, 28, 37, 51, 64, 67, 87, 113, 129, 132, 136, 142, 152, 155, 163, 165, 171, 173, and 191, and full-length complementary
sequences thereof, and
a second combination of 25 different probes respectively comprising the sequences set forth in SEQ ID NOs:2, 4, 7, 13, 18,
20, 25, 26, 34, 38, 42, 46, 55, 70, 79, 83, 86, 92, 105, 114, 119, 124, 172, 179, and 183, and full-length complementary sequences
thereof.
|